Glutamine and trehalose compositions

A method of treating or preventing mucositis, comprising swishing a liquid comprising a pharmaceutical composition comprising glutamine at 10-40% dry weight and trehalose at 10-60% dry weight and a pharmaceutically acceptable carrier reconstituted or formulated as a viscous fluid of at least 100 cP at 37° C. in a patient's mouth, said patient being at risk of having or having mucositis, and swallowing the liquid.

A method of treating or preventing mucositis, comprising:

• i) a patient at risk of or having mucositis swishing a liquid pharmaceutical composition comprising glutamine at 10-40% dry weight and trehalose at 10-60% dry weight and a pharmaceutically acceptable carrier in said patient's mouth, and ii) said patient swallowing said liquid.

A method of providing cellular nutritional support, comprising administering a pharmaceutical composition comprising glutamine at 10-40% dry weight and trehalose at 10-60% dry weight and a pharmaceutically acceptable carrier to a patient having cellular stress in an amount sufficient to provide cellular nutritional support.

A method of treating oral mucositis, comprising swishing a liquid comprising a pharmaceutical composition comprising glutamine glutamine at 10-40% dry weight and trehalose at 10-60% dry weight and a pharmaceutically acceptable carrier formulated as a viscous fluid of at least 100 cP at 37° C. in a patient's mouth, said patient having mucositis, and said patient swallowing the liquid.

A method of treating oral mucositis, said method comprising:

• i) swishing a liquid pharmaceutical composition comprising glutamine at 10-40% dry weight and trehalose at 10-60% dry weight and a pharmaceutically acceptable carrier in a mouth of a patient having mucositis, and ii) swallowing said liquid.